Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID ‐19 among people with type 2 diabetes: A case‐control study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID ‐19 among people with type 2 diabetes: A case‐control study

Published:2020-07 Issue:10 Volume:22 Page:1946-1950
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Fadini Gian Paolo¹^ORCID,Morieri Mario Luca¹,Longato Enrico²,Bonora Benedetta Maria¹,Pinelli Silvia¹,Selmin Elisa¹,Voltan Giacomo¹,Falaguasta Daniele¹,Tresso Silvia¹,Costantini Giorgia¹,Sparacino Giovanni²,Di Camillo Barbara²,Tramontan Lara³,Cattelan Anna Maria⁴,Vianello Andrea⁵,Fioretto Paola¹^ORCID,Vettor Roberto¹,Avogaro Angelo¹^ORCID

Affiliation:

1. Department of Medicine University of Padova Padova Italy

2. Department of Information Engineering University of Padova Padova Italy

3. Arsenàl.IT, Veneto Region Treviso Italy

4. Unit of Infectious Disease University Hospital of Padova Padova Italy

5. Department of Cardiothoracic Vascular Sciences and Public Health University of Padova Padova Italy

Funder

Università degli Studi di Padova

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14097

Reference15 articles.

1. Molecular basis of binding between middle east respiratory syndrome coronavirus and CD26 from seven bat species;Yuan Y;J Virol.,2020

2. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

3. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

4. Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26

5. The structure and function of CD26 in the T-cell immune response

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequency of Mortality and Adverse Outcomes of COVID-19 in Hospitalized Type 2 Diabetics with a History of Sitagliptin or Metformin Use;Jundishapur Journal of Chronic Disease Care;2024-05-07

2. The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies;Therapeutic Innovation & Regulatory Science;2024-04-29

3. Therapeutic Repurposing of Antidiabetic Drugs in Diabetes-associated Comorbidities;Current Drug Therapy;2024-03

4. Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients;Scientific Reports;2023-10-27

5. Factors influencing the severity of COVID-19 course for patients with diabetes mellitus in tashkent: a retrospective cohort study;Obesity and metabolism;2023-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3